Clinical Trial

Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction

Study acronym: TOGETHR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2023 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Transgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of HIV and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers delivered by peers in one-on-one or small-group settings may be effective at increasing PrEP engagement. This study examines the independent and combined effects of individual and group-based peer-support interventions on PrEP outcomes. Participants will be randomly assigned to receive: (i) standard-of-care HIV prevention information, (ii) a one-on-one healthy lifestyle intervention tailored for transgender masculine people, (iii) a peer-group based healthy lifestyle intervention for transgender masculine people, or (iv) both the one-on-one and group-based interventions delivered together. The hypotheses are that the individual group-based interventions will result in higher PrEP uptake and persistence than the standard of care and that the combined interventions will be more effective than receiving one individual intervention.
Trial Details
NCT Number NCT06182280
Lead Sponsor Fenway Community Health
Collaborators: National Institute of Mental Health (NIMH)
Conditions HIV Infections, Adherence, Medication
Enrollment 375 participants
Start Date 2024-01
Primary Completion 2026-07 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2023-12-26